PDF Boulanger C-M,
Liang C, Russell RS, Lin R, Bedford MT, Wainberg MA,
Richard S. Methylation of TAT by PRMT6 regulates HIV-1
gene expression. Journal of Virology, 79: 124-131, 2005.
PDF Swiercz R, Person
MD, Bedford MT. Ribosomal protein S2 is a
substrate for mammalian protein arginine methyltransferase 3 (PRMT3).
Biochem J, 386: 85-91, 2005.
PDF Covic M, Hassa
PO, Saccani S, Buerki C, Meier NI, Lombardi C, Imhof R, Bedford MT, Natoli G, Hottiger MO. Arginine
methyltransferase CARM1 is a promoter-specific regulator of
NF-kappaB-dependent gene expression. EMBO J, 24: 85-96, 2005.
PDF Bedford MT and Richard S. Arginine methylation: An emerging
regulator of protein function. Molecular Cell, 18: 263-272, 2005.
PDF Ludes-Meyers JH,
Kil H, Bednarek AK, Drake J, Bedford MT, Aldaz CM. WWOX binds the specific proline-rich ligand PPXY:
Identification of interacting proteins. Oncogene, 23: 5049-5055, 2004.
PDF Cheng D, Yadav
N, King RW, Swanson MS, Weinstein EJ, Bedford MT. Small molecule regulators of protein arginine
methyltransferases. J Biol Chem, 279: 23892-23899, 2004.
PDF Kim J, Lee J,
Yadav N, Wu Q, Carter C, Richard S, Richie E, Bedford MT. Loss of CARM1 results in hypomethylation of
TARPP and deregulated early T cell development. J Biol Chem, 279:
25339-25344, 2004.
PDF Cote J, Boisvert FM, Boulanger MC, Bedford MT, Richard S. Sam68 is an in vivo substrate for protein arginine
N-methyltransferase 1. Molecular Biology of the Cell, 14: 274-287, 2003.
PDF Yadav N, Lee J,
Kim J, Shen J, Hu MC-T, Aldaz CM, Bedford MT. Specific protein methylation defects and gene
expression perturbations in CARM1-deficient mice. PNAS, 100: 6464-6468, 2003.
PDF Sotgia F,
Bonuccelli G, Bedford MT, Brancaccio A, Mayer U,
Wilson MT, Campos-Gonzalez R, Brooks JW, Sudol M, Lisanti
MP. Localization of phospho-beta-dystroglycan (pY892) to an intracellular
vesicular compartment in cultured cells and skeletal muscle fibers in
vivo. Biochemistry, 42: 7110-7123, 2003.
PDF Ludes-Meyers JH,
Bednarek AK, Popescu N, Bedford MT, Aldaz CM. WWOX, the common chromosomal fragile site, FRA16D,
cancer gene. Cytogenetics and Genome Research, 100: 101-110, 2003.
PDF Aasland R, Abrams C, Ampe C, Ball LJ, Bedford MT,
Cesareni G, Gimona M, Hurley JH, Jarchau T, Lehto VP, Lemmon MA, Linding R, Mayer BJ, Nagai M, Sudol M, Walter U, Winder SJ. Normalization of nomenclature for peptide motifs
as ligands of modular protein domains. FEBS Letters, 513: 141-144, 2002.
PDF Frankel A, Yadav N, Lee J, Branscombe TL, Clarke S, Bedford MT. The novel human protein arginine N-methyltransferase PRMT6 is a nuclear
enzyme displaying unique substrate specificity. J Biol Chem, 277:
3537-3543, 2002.
PDF Lee J and Bedford MT. PABP1 identified as an arginine
methyltransferase substrate using high-density protein arrays. EMBO
Reports, 3: 268-273, 2002.
PDF Espejo A, Cote J, Bednarek A, Richard S, Bedford MT. A protein-domain microarray identifies novel protein-protein
interactions. Biochem Jrnl, 367: 697-702, 2002.
PDF Liu MY, Cai CS, Espejo A, Bedford MT, Walker CL. 14-3-3 proteins interact with the tumor suppressor tuberin at AKT
phosphorylation site(s). Cancer Research, 62: 6475-6480, 2002.
PDF Goldstrohm AC,
Albrecht TR, Sune C, Bedford MT, Garcia-Blanco MA. The transcription elongation factor CA150 interacts with RNA polymerase
II and the pre-mRNA splicing factor SF1. MCB, 21:7617-7628, 2001.
PDF Sotgia F, Lee H, Bedford MT, Petrucci T, Sudol M, Lisanti MP.
Tyrosine phosphorylation of beta-dystroglycan at its WW domain binding
motif, PPxY, recruits SH2 domain containing proteins. Biochemistry, 40:
14585-14592, 2001.
Bedford MT and Leder P. The FF domain: A novel motif that often accompanies WW domains. TIBS,
24: 253-290, 1999.
Rentschler S, Linn H, Deininger K, Bedford MT, Espanel X, Sudol M. The WW domain of
dystrophin requires EF-hands region to interact with beta-dystroglycan.
Biol Chem, 380: 431-442, 1999.
Bedford MT, Reed R, Leder P.
WW domain-mediated interactions reveal a spliceosome-associated protein
that binds a third class of proline-rich motif: The proline glycine and
methionine-rich motif. PNAS, 95: 10602-10607, 1998.
Bedford MT, Chan DC, Leder P.
FBP WW domains and the Abl SH3 domain bind to a specific class of
proline-rich ligands. EMBO J, 16: 2376-2383, 1997.
Deng X, Bedford MT, Li C, Xu X, Yang X, Dunmore J, Leder P.
Fibroblast growth factor receptor-1 (FGFR1) is essential for normal
neural tube and limb development. Developmental Biology, 185: 42-54, 1997.
Chan DC, Bedford MT, Leder P.
Formin binding proteins bear WWP/WW domains that bind
proline-rich
peptides and functionally resemble SH3 domains. EMBO J,
15:
1045-1054, 1996.
Abud HE, Skinner JA, McDonald FJ, Bedford MT, Lonai P, Heath JK.
Ectopic expression of Fgf-4 in chimeric mouse embryos
induces the
expression of early markers of limb development in the lateral
ridge.
Developmental Genetics, 19: 51-65, 1996.
Bedford MT, Arman E, Orr-Urtreger A, Lonai P.
Analysis of the Hoxd-3 Gene: Structure and localization of
its sense
and antisense transcripts. DNA Cell Biol, 14: 295-304, 1995.
Hecht D, Zimmerman N, Bedford MT, Avivi A, Yayon
A. Identification of fibroblast growth factor 9 (FGF9) as a
high
affinity, heparin dependent ligand for FGF receptors 3 and 2 but not
for FGF receptors 1 and 4. Growth Factors, 12: 223-233, 1995.
Orr-Urtreger A*, Bedford MT*,
Burakova T, Arman E, Zimmer Y, Yayon A, Givol D, Lonai P.
Developmental localization of the splicing alternatives of
fibroblast
growth factor receptor-2 (FGFR2). Developmental Biology,
158:
475-486, 1993. *First two authors contributed equally.
Orr-Urtreger A, Bedford MT,
Do M-S, Eisenbach L, Lonai P.
Developmental expression of the A receptor for the platelet
derived
growth factor, which is deleted in the embryonic lethal patch
mutation. Development, 115: 289-303, 1992.
Bedford MT and van Helden PD.
Analysis of allele-specific methylation.
TIGS, 6: 140-141, 1990.
van der Merwe AE, Mattheyse FJ, Bedford MT, van Helden PD, Rossouw DJ. Allografted keratinocytes used to accelerate the treatment
of burn
wounds are replaced by recipient cells. Burns, 16:
193-197, 1990.
Bedford MT and van Helden PD.
Hypomethylation of DNA in pathological conditions of the
human prostate. Cancer Research, 47: 5274-5276, 1987. |